Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | PRKCA | P17252 | 4/20 | 0.45 |
| ▸ | AR | P10275 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Triacetin SCHEMBL28108103 | 0.92 | TDP1 (0.43) | TDP1PRKCAARGAA | |
| SCHEMBL11172217 | 0.91 | TSHR (0.43) | TDP1PRKCAALDH1A1LMNATSHR | |
| Triacetin SCHEMBL3870 | 0.91 | TDP1 (0.56) | TDP1PRKCAARGAAALDH1A1 | |
| Triacetin SCHEMBL821340 | 0.91 | TDP1 (0.56) | TDP1PRKCAARGAAALDH1A1 | |
| Triacetin SCHEMBL8954226 | 0.89 | TDP1 (0.50) | TDP1PRKCAARGAAALDH1A1 | |
| Triacetin SCHEMBL1698261 | 0.89 | TDP1 (0.50) | TDP1PRKCAARGAAALDH1A1 | |
| Triacetin SCHEMBL3901859 | 0.89 | PRKCA (0.50) | TDP1PRKCAARGAAALDH1A1 | |
| Triacetin SCHEMBL8012678 | 0.89 | TDP1 (0.54) | TDP1PRKCAARGAAALDH1A1 | |
| Triacetin SCHEMBL16446056 | 0.89 | TDP1 (0.54) | TDP1PRKCAARGAAALDH1A1 | |
| Triacetin SCHEMBL16445622 | 0.89 | TDP1 (0.54) | TDP1PRKCAARGAAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230288610-A1 | WAVELENGTH SELECTIVE ABSORPTION FILTER AND DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2023-09-14 | — | — | US | disclosed |
| WO-2022138082-A1 | ACTIVE-ENERGY-CURABLE HARD COAT AGENT, HARD COAT LAYER, AND LAMINATE | 東洋インキＳＣホールディングス株式会社 | 2022-06-30 | — | — | WO | disclosed |
| US-20200283464-A1 | GLYCOSAMINOGLYCAN ESTER AND APPLICATION THEREOF | CHENGDU AULI ECOLOGICAL TECHNOLOGY DEVELOPMENT CO., LTD. (CN) | 2020-09-10 | — | — | US | disclosed |
| US-20180092915-A1 | SODIUM CHANNEL BLOCKERS FOR SKIN DISORDERS | PARION SCIENCES, INC. (US) | 2018-04-05 | — | — | US | disclosed |
| US-9849129-B2 | Sodium channel blockers for skin disorders | PARION SCIENCES, INC. (US) | 2017-12-26 | — | — | US | disclosed |
| WO-2016133967-A2 | SODIUM CHANNEL BLOCKERS FOR SKIN DISORDERS | PARION SCIENCES, INC. (US) | 2016-08-25 | — | — | WO | disclosed |
| US-9354356-B2 | Polymer film, and optically-compensatory film, polarizer and liquid-crystal display device comprising the same | FUJIFILM CORPORATION (JP) | 2016-05-31 | — | — | US | disclosed |
| US-20130253182-A1 | POLYMER FILM, AND OPTICALLY-COMPENSATORY FILM, POLARIZER AND LIQUID-CRYSTAL DISPLAY DEVICE COMPRISING THE SAME | NISHIURA TAKAKO (JP) | 2013-09-26 | — | — | US | disclosed |
| US-8153731-B2 | Comb (block) copolymers | BYK=Chemie GmbH (DE) | 2012-04-10 | — | — | US | disclosed |
| US-7858560-B2 | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions | CAPROTEC BIOANALYTICS GMBH (DE) | 2010-12-28 | — | — | US | disclosed |
| US-20100099813-A1 | Comb (block) copolymers | BYK-CHEMIE GMBH (DE) | 2010-04-22 | — | — | US | disclosed |
| US-7288119-B2 | Leather treatment | AUTOMOTIVE TECHNOLOGY, INC. (US) | 2007-10-30 | — | — | US | disclosed |
| US-20060042018-A1 | Quick-drying non-aqueous, thermoplastic leather dye of dye or pigment dispersed in polyacrylate resin, C-3 and C-4 alcohol mixture, n-butyl acetate, and propylene glycol monomethyl ether; dryable in less than one minute | AUTOMOTIVE TECHNOLOGY, INC. | 2006-03-02 | — | — | US | disclosed |
| US-7001435-B2 | Method for dying leather with propylene glycol monomethyl ether (PGME) systems comprising adding polyacrylate resin base, C3 and C4 alcohols, and n-butyl acetate and negating the need for teflon dispersions, dibutyl phthalate, and improve | AUTOMOTIVE TECHNOLOGY, INC. (US) | 2006-02-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180092915-A1 | SODIUM CHANNEL BLOCKERS FOR SKIN DISORDERS | SCNN1B, SCNN1A, SCNN1G | TDP1 2579/4885PRKCA 1361/4885AR 3225/4885 |
| US-20200283464-A1 | GLYCOSAMINOGLYCAN ESTER AND APPLICATION THEREOF | LIPG, FABP4, ALPG | TDP1 3734/4885PRKCA 2249/4885AR 1084/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.